METASTATIC CARCINOID TUMOUR

This adverse event was reported 105 times

These drugs are most commonly taken by patients reporting METASTATIC CARCINOID TUMOUR:

# Drug Count
0 OCTREOTIDE ACETATE 46
1 EVEROLIMUS 16
2 ESCITALOPRAM 6
3 METFORMIN 6
4 METFORMIN ER 500 MG 6
5 METFORMIN ER 750 MG 6
6 PANTOPRAZOLE 6
7 TELOTRISTAT ETHYL 6
8 WARFARIN 6
9 BREXPIPRAZOLE 5
See all common drugs associated with METASTATIC CARCINOID TUMOUR

METASTATIC CARCINOID TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OCTREOTIDE ACETATE 46 0.0015
1 TELOTRISTAT ETHYL 6 0.0010
2 PASIREOTIDE 2 0.0009
3 ACYCLOVIR SODIUM 1 0.0008
4 LUTETIUM LU 177 DOTATATE 4 0.0007
5 CYCLOBENZAPRINE HYDROCHLORIDE 4 0.0004
6 EVEROLIMUS 16 0.0003
7 BREXPIPRAZOLE 5 0.0003
8 PAMIDRONATE DISODIUM 1 0.0003
9 EVEROLIMUS TABLETS 4 0.0002
See all drugs enriched for association with METASTATIC CARCINOID TUMOUR

METASTATIC CARCINOID TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Somatostatin Analog [EPC] 4 0.0006
1 Prostaglandin E1 Analog [EPC] 1 0.0001
2 Aromatase Inhibitor [EPC] 5 0.0000
3 Kinase Inhibitor [EPC] 19 0.0000
4 Nicotinic Acid [EPC] 2 0.0000
5 Nitroimidazole Antimicrobial [EPC] 2 0.0000
6 Expectorant [EPC] 5 0.0000
7 Folate Analog [EPC] 1 0.0000
8 Vitamin A [EPC] 1 0.0000
9 Opioid Agonist [EPC] 5 0.0000
See all drug classes enriched for association with METASTATIC CARCINOID TUMOUR